Skip to main content
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1999 Mar;36(3):183–186.

Evaluation of a mutation screening strategy for sporadic cases of ATR-X syndrome

L Villard 1, M Bonino 1, F Abidi 1, A Ragusa 1, J Belougne 1, A Lossi 1, L Seaver 1, J Bonnefont 1, C Romano 1, M Fichera 1, D Lacombe 1, A Hanauer 1, N Philip 1, C Schwartz 1, M Fontes 1
PMCID: PMC1734331  PMID: 10204841

Abstract

We report on the evaluation of a strategy for screening for XNP/ATR-X mutations in males with mental retardation and associated dysmorphology. Because nearly half of the mutations in this gene reported to date fall into a short 300 bp region of the transcript, we decided to focus in this region and to extend the mutation analysis to cases with a negative family history. This study includes 21 mentally retarded male patients selected because they had severe mental retardation and a typical facial appearance. The presence of haemoglobin H or urogenital abnormalities was not considered critical for inclusion in this study. We have identified six mutations which represents a mutation detection rate of 28%. This figure is high enough for us to propose this strategy as a valid first level of screening in a selected subset of males with mental retardation. This approach is simple, does not require RNA preparation, does not involve time consuming mutation detection methods, and can thus be applied to a large number of patients at a low cost in any given laboratory.


Keywords: mental retardation; ATR-X; mutation; zinc finger

Full Text

The Full Text of this article is available as a PDF (137.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Gibbons R. J., Bachoo S., Picketts D. J., Aftimos S., Asenbauer B., Bergoffen J., Berry S. A., Dahl N., Fryer A., Keppler K. Mutations in transcriptional regulator ATRX establish the functional significance of a PHD-like domain. Nat Genet. 1997 Oct;17(2):146–148. doi: 10.1038/ng1097-146. [DOI] [PubMed] [Google Scholar]
  2. Gibbons R. J., Brueton L., Buckle V. J., Burn J., Clayton-Smith J., Davison B. C., Gardner R. J., Homfray T., Kearney L., Kingston H. M. Clinical and hematologic aspects of the X-linked alpha-thalassemia/mental retardation syndrome (ATR-X). Am J Med Genet. 1995 Jan 30;55(3):288–299. doi: 10.1002/ajmg.1320550309. [DOI] [PubMed] [Google Scholar]
  3. Gibbons R. J., Picketts D. J., Villard L., Higgs D. R. Mutations in a putative global transcriptional regulator cause X-linked mental retardation with alpha-thalassemia (ATR-X syndrome). Cell. 1995 Mar 24;80(6):837–845. doi: 10.1016/0092-8674(95)90287-2. [DOI] [PubMed] [Google Scholar]
  4. Gibbons R. J., Suthers G. K., Wilkie A. O., Buckle V. J., Higgs D. R. X-linked alpha-thalassemia/mental retardation (ATR-X) syndrome: localization to Xq12-q21.31 by X inactivation and linkage analysis. Am J Hum Genet. 1992 Nov;51(5):1136–1149. [PMC free article] [PubMed] [Google Scholar]
  5. Villard L., Gecz J., Mattéi J. F., Fontés M., Saugier-Veber P., Munnich A., Lyonnet S. XNP mutation in a large family with Juberg-Marsidi syndrome. Nat Genet. 1996 Apr;12(4):359–360. doi: 10.1038/ng0496-359. [DOI] [PubMed] [Google Scholar]
  6. Villard L., Lacombe D., Fontés M. A point mutation in the XNP gene, associated with an ATR-X phenotype without alpha-thalassemia. Eur J Hum Genet. 1996;4(6):316–320. doi: 10.1159/000472225. [DOI] [PubMed] [Google Scholar]
  7. Villard L., Lossi A. M., Cardoso C., Proud V., Chiaroni P., Colleaux L., Schwartz C., Fontés M. Determination of the genomic structure of the XNP/ATRX gene encoding a potential zinc finger helicase. Genomics. 1997 Jul 15;43(2):149–155. doi: 10.1006/geno.1997.4793. [DOI] [PubMed] [Google Scholar]
  8. Villard L., Toutain A., Lossi A. M., Gecz J., Houdayer C., Moraine C., Fontès M. Splicing mutation in the ATR-X gene can lead to a dysmorphic mental retardation phenotype without alpha-thalassemia. Am J Hum Genet. 1996 Mar;58(3):499–505. [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES